Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate a Patient Satisfaction Questionnaire for Anemia
Treatment (PSQ-AT) in non small cell lung cancer patients treated with darbepoetin alfa or
recombinant human erythropoietin (rHuEPO) for anemia due to chemotherapy.